The trading price of CorMedix Inc (NASDAQ:CRMD) closed lower on Friday, January 17, and closing at $12.17, -4.85% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $12.14 and $13.09. In examining the 52-week price action we see that the stock hit a 52-week high of $13.85 and a 52-week low of $2.89. Over the past month, the stock has gained 46.45% in value.
CorMedix Inc, whose market valuation is $738.44 million at the time of this writing, is expected to release its quarterly earnings report in February. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0.12 per share this quarter, however they have predicted annual earnings per share of -0.4 for current year and 0.57 for next year.
Analysts have forecast the company to bring in revenue of 27.46M for the current quarter, with the likely lows of 20.5M and highs of 31.1M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 40.63M.
On the technical side, indicators suggest CRMD has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned CRMD a recommendation rating is 2. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged CorMedix Inc (CRMD) as Underweight, while 1 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that CRMD’s price is currently 27.40% off the SMA20 and 23.33% off the SMA50. The RSI metric on the 14-day chart is currently showing 69.19, and weekly volatility stands at 7.37%. When measured over the past 30 days, the indicator reaches 6.48%. CorMedix Inc (NASDAQ:CRMD)’s beta value is currently sitting at 1.54, while the Average True Range indicator is currently displaying 0.73. With analysts defining $9-$9 as the low and high price targets, we arrive at a consensus price target of $9 for the trailing 12-month period. The current price is about 26.05% off the estimated low and 26.05% off the forecast high, based on this estimate. Investors will be thrilled if CRMD’s share price rises to $9, which is the median consensus price. At that level, CRMD’s share price would be 26.05% above current price.
To see how CorMedix Inc stock has been performing in comparison to its peers in the industry, here are the numbers: CRMD stock’s performance was -4.85% in the latest trading, and 263.28% in the past year.
An evaluation of the daily trading volume of CorMedix Inc (NASDAQ:CRMD) indicates that the 3-month average is 1.27 million. However, this figure has increased over the past 10 days to an average of 1.79.
Currently, records show that 60.68 million of the company’s shares remain outstanding. The insiders hold 2.16% of outstanding shares, whereas institutions hold 31.46%. The stats also highlight that short interest as of 2024-12-31, stood at 7.0 million shares, resulting in a short ratio of 7.94 at that time. From this, we can conclude that short interest is 1155.00 of the company’s total outstanding shares. It is noteworthy that short shares in December were up slightly from the previous month’s figure, which was 6.89 million. However, since the stock’s price has seen 50.25% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
